Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sugemalimab, a fully human, full-length, IgG4 monoclonal antibody (mAb) targeting programmed death ligand 1 (PD-L1), exhibits anticancer activities and is applicable in non-small cell lung cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $687 | 2-4 weeks | |
5 mg | $1,780 | 2-4 weeks | |
10 mg | $2,380 | 2-4 weeks | |
25 mg | $3,570 | 2-4 weeks | |
50 mg | $4,790 | 2-4 weeks | |
100 mg | $6,480 | 2-4 weeks |
Description | Sugemalimab, a fully human, full-length, IgG4 monoclonal antibody (mAb) targeting programmed death ligand 1 (PD-L1), exhibits anticancer activities and is applicable in non-small cell lung cancer research [1]. |
Cas No. | 2256084-03-2 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.